Colomba E, Jonas SF, Eymard JC, Delva R, et al. A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA. Eur Urol 2023 Jun 2:S0302-2838(23)02814-2. doi: 10.1016/j.eururo.2023.
PMID: 37271630